Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

This summary is generated by an algorithm. If you find any mistakes, let us know.

Anjarium Biosciences Raises $61M in Series A Financing
Anjarium Biosciences Raises $61M in Series A Financing
UN

Unicorn Nest news

Anjarium Biosciences Raises $61M in Series A Financing

- Anjarium Biosciences AG is a Schliren, Zurich-based biotech company focused on creating and delivering a new class of non-viral gene therapies. - Series A funding closed at $61m. - The round was co-led by Abingworth and Gimv, with participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company). - The new investment will be used to advance the company's pipeline programs towards clinical development.

Source
Anjarium Biosciences Raises $61M in Series A Financing
Anjarium Biosciences Raises $61M in Series A Financing
UN

Unicorn Nest news

Anjarium Biosciences Raises $61M in Series A Financing

- Anjarium Biosciences AG is a Schliren, Zurich-based biotech company focused on creating and delivering a new class of non-viral gene therapies. - Series A funding closed at $61m. - The round was co-led by Abingworth and Gimv, with participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company). - The new investment will be used to advance the company's pipeline programs towards clinical development.

Source
1 2 3 … 58 59 60
Crunchbase icon

Content report

The following text will be sent to our editors:

Send